Explore company profiles, quarterly results, announcements and ownership disclosures.
Loading the company view…
Epigral Limited (NSE: EPIGRAL), ISIN INE071N01016 — earnings, PEAD surprise, concall summary, Walk-the-Talk management consistency, SAST and insider filings, and the EquiSense Score (ECS), all in plain English on EquiSense.
EPIGRAL last traded at ₹894.55 (-2.04%), with a 52-week range of ₹807.00 to ₹1669.40 (as of 6 Nov 2026).
Shareholding as of Sep 2026: promoters 68.83%, FIIs 0.99%, DIIs 4.89%, mutual funds 4.87%.
EquiSense Score (ECS): 75/100.
Data sourced from NSE and BSE filings. Educational — not investment advice.